Status:
COMPLETED
Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Dana-Farber Cancer Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
45-65 years
Phase:
NA
Brief Summary
The purpose of this study is to develop and evaluate a computer-based decision aid (DA) for use by men considering prostate-specific antigen (PSA) screening for prostate cancer. Major medical organiza...
Detailed Description
Prostate cancer (CaP) is a formidable public health problem in the US and in industrialized countries worldwide. Methods for primary prevention of CaP are unknown. As a result, early detection has bec...
Eligibility Criteria
Inclusion
- Worksites employing at least 100 men in target age group (45-65 years old)
Exclusion
- Worksites with high turnover
- Non-English speaking workers
- Temporary or contract workers
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
812 Patients enrolled
Trial Details
Trial ID
NCT00207636
Start Date
December 1 2004
End Date
August 1 2009
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215